Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MBX Biosciences is a US-based biotechnology company specializing in the development of precision medicine therapies. The company focuses on peptide therapeutics to treat endocrine and metabolic disorders. Through innovative research, MBX Biosciences addresses hormone deficiencies with targeted solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MBX Biosciences is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MBX Biosciences last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.78 USD.
MBX Biosciences has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.